Drug based on CAR T-Cell Market Report – Research, Industry Analysis Reports and Market Demands

Global Drug based on CAR T-Cell Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug based on CAR T-Cell by Type
- 1.3.1 Overview: Global Drug based on CAR T-Cell Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Drug based on CAR T-Cell Consumption Value Market Share by Type in 2024
- 1.3.3 CD19-targeted
- 1.3.4 BCMA-targeted
1.4 Global Drug based on CAR T-Cell Market by Application
- 1.4.1 Overview: Global Drug based on CAR T-Cell Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Lymphoma
- 1.4.3 Multiple Myeloma
1.5 Global Drug based on CAR T-Cell Market Size & Forecast
1.6 Global Drug based on CAR T-Cell Market Size and Forecast by Region
- 1.6.1 Global Drug based on CAR T-Cell Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Drug based on CAR T-Cell Market Size by Region, (2020-2031)
- 1.6.3 North America Drug based on CAR T-Cell Market Size and Prospect (2020-2031)
- 1.6.4 Europe Drug based on CAR T-Cell Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Drug based on CAR T-Cell Market Size and Prospect (2020-2031)
- 1.6.6 South America Drug based on CAR T-Cell Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Drug based on CAR T-Cell Market Size and Prospect (2020-2031)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Drug based on CAR T-Cell Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Drug based on CAR T-Cell by Company Revenue
- 3.2.2 Top 3 Drug based on CAR T-Cell Players Market Share in 2024
- 3.2.3 Top 6 Drug based on CAR T-Cell Players Market Share in 2024
3.3 Drug based on CAR T-Cell Market: Overall Company Footprint Analysis
- 3.3.1 Drug based on CAR T-Cell Market: Region Footprint
- 3.3.2 Drug based on CAR T-Cell Market: Company Product Type Footprint
- 3.3.3 Drug based on CAR T-Cell Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Drug based on CAR T-Cell Consumption Value and Market Share by Type (2020-2025)
4.2 Global Drug based on CAR T-Cell Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

5.1 Global Drug based on CAR T-Cell Consumption Value Market Share by Application (2020-2025)
5.2 Global Drug based on CAR T-Cell Market Forecast by Application (2026-2031)

6 North America

6.1 North America Drug based on CAR T-Cell Consumption Value by Type (2020-2031)
6.2 North America Drug based on CAR T-Cell Market Size by Application (2020-2031)
6.3 North America Drug based on CAR T-Cell Market Size by Country
- 6.3.1 North America Drug based on CAR T-Cell Consumption Value by Country (2020-2031)
- 6.3.2 United States Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 6.3.3 Canada Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Drug based on CAR T-Cell Market Size and Forecast (2020-2031)

7 Europe

7.1 Europe Drug based on CAR T-Cell Consumption Value by Type (2020-2031)
7.2 Europe Drug based on CAR T-Cell Consumption Value by Application (2020-2031)
7.3 Europe Drug based on CAR T-Cell Market Size by Country
- 7.3.1 Europe Drug based on CAR T-Cell Consumption Value by Country (2020-2031)
- 7.3.2 Germany Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 7.3.3 France Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 7.3.5 Russia Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 7.3.6 Italy Drug based on CAR T-Cell Market Size and Forecast (2020-2031)

8 Asia-Pacific

8.1 Asia-Pacific Drug based on CAR T-Cell Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Drug based on CAR T-Cell Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Drug based on CAR T-Cell Market Size by Region
- 8.3.1 Asia-Pacific Drug based on CAR T-Cell Consumption Value by Region (2020-2031)
- 8.3.2 China Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 8.3.3 Japan Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 8.3.5 India Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 8.3.7 Australia Drug based on CAR T-Cell Market Size and Forecast (2020-2031)

9 South America

9.1 South America Drug based on CAR T-Cell Consumption Value by Type (2020-2031)
9.2 South America Drug based on CAR T-Cell Consumption Value by Application (2020-2031)
9.3 South America Drug based on CAR T-Cell Market Size by Country
- 9.3.1 South America Drug based on CAR T-Cell Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Drug based on CAR T-Cell Market Size and Forecast (2020-2031)

10 Middle East & Africa

10.1 Middle East & Africa Drug based on CAR T-Cell Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Drug based on CAR T-Cell Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Country
- 10.3.1 Middle East & Africa Drug based on CAR T-Cell Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Drug based on CAR T-Cell Market Size and Forecast (2020-2031)
- 10.3.4 UAE Drug based on CAR T-Cell Market Size and Forecast (2020-2031)

11 Market Dynamics

11.1 Drug based on CAR T-Cell Market Drivers
11.2 Drug based on CAR T-Cell Market Restraints
11.3 Drug based on CAR T-Cell Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Drug based on CAR T-Cell Industry Chain
12.2 Drug based on CAR T-Cell Upstream Analysis
12.3 Drug based on CAR T-Cell Midstream Analysis
12.4 Drug based on CAR T-Cell Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Drug based on CAR T-Cell market size was valued at US$ 425 million in 2024 and is forecast to a readjusted size of USD 673 million by 2031 with a CAGR of 6.8% during review period.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Drug based on CAR T-Cell market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug based on CAR T-Cell market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drug based on CAR T-Cell market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drug based on CAR T-Cell market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drug based on CAR T-Cell market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug based on CAR T-Cell
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug based on CAR T-Cell market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), CARsgen Therapeutics, Autolus Therapeutics, Sorrento Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug based on CAR T-Cell market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
CD19-targeted
BCMA-targeted
Market segment by Application
Lymphoma
Multiple Myeloma
Market segment by players, this report covers
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug based on CAR T-Cell product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug based on CAR T-Cell, with revenue, gross margin, and global market share of Drug based on CAR T-Cell from 2020 to 2025.
Chapter 3, the Drug based on CAR T-Cell competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug based on CAR T-Cell market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug based on CAR T-Cell.
Chapter 13, to describe Drug based on CAR T-Cell research findings and conclusion.

Buy now